Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock. Separately, Alliance Global Partners boosted their price objective on shares of Tonix Pharmaceuticals from $6.00 to $11.00 and […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Downgrades Minerals Technologies (NYSE:MTX) to Hold
Next post Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com